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In an experimental model of unilateral pneumonia caused by Klebsiella pneumoniae in rats we investigated whether 
intravenous administration of liposomes with prolonged blood circulation time resulted in significant localization of 
l iposomes in infected lung tissue. Liposomes (I00 nm) composed of hydrogenated phosphatidyl- 
inositol : hydrogenated phosphatidylcholine : cholesterol (molar ratio, 1 : I0: 5) radiolabeled with gallium-67-de- 
feroxamine showed relatively long blood circulation time. The degree of localization of these long circulating 
liposomes in the infected left lung was significantly higher compared to that of localization of II0 nm egg 
phosphatidylglycerol : egg phosphatidylcholine : cholesterol (molar ratio, 1 : I0 : 5) liposomes which exhibited rela- 
tively short blood circulation time. At 16 h after administration of the long circulating liposomes (when 10% of the 
injected dose was still present in the bloodstream) localization of liposomes in the infected left lung was increased 
up to 10-fold compared to the left lung of uninfected rats, and appeared to be highly correlated with the intensity of 
the infection. In the uninfected right lung the localization of long circulating liposomes was not increased. The 
degree of localization of liposomes in the infected tissue is dependent on the residence time of liposomes in the 
blood compartment. The extent of localization of long circulating liposomes in infected tissue appeared to be 
dependent on the liposomal dose administered. 
Introduction 
It is well-known from clinical experience that, de- 
spite the availability of potent antibiotics, infections 
are still a major cause of morbidity and mortality. 
There is an evident herapeutic need for improvement 
of antibiotic treatment which should result in increased 
antibiotic concentrations in infected tissues or in in- 
fected cells, and in reduced toxicity of potentially toxic 
antibiotics. Application of liposomes as carriers of an- 
timicrobial agents has been proposed as a potential 
way to increase the selective delivery of the antimicro- 
bial agents to their target sites. Unfortunately, some 
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major problems have not yet been solved. Directing 
liposomes to infected tissues and cells other than liver 
and spleen is hampered by preferential uptake of intra- 
venously administered liposomes by cells of the 
mononuclear phagocyte system (MPS) particularly 
those residing in liver and spleen. Accordingly, it is not 
surprising that most experimental data on the use of 
liposomes as carriers of antibiotics are derived from 
animal models of intracellular infections involving the 
MPS [1-7]. In these studies an improved therapeutic 
effect and/or reduced toxicity resulting from encapsu- 
lation of the antibiotics in liposomes have been demon- 
strated. Effective targeting of liposomes to non-MPS 
tissues would require avoidance of uptake by the MPS. 
Recent work has shown that specific changes in the 
liposome composition can drastically reduce the rate 
and extent of uptake by the liver and spleen. Such 
liposomes can circulate in the blood for prolonged 
periods of time, when compared to 'conventional' lipo- 
somes with lipid compositions usually used. Studies of 
Gabizon et al. and Allen et al. show important progress 
in this respect [8-12]. They evaluated the biodistribu- 
tion of a series of liposome formulations differing in 
mean particle size and lipid composition. They found 
that specific liposome formulations with prolonged 
blood circulation time showed enhanced localization in 
areas of implanted tumors in mice. In this study it was 
investigated whether infected tissue is more accessible 
to long circulating liposomes than to conventional (short 
circulating) liposomes. In addition, it was studied 
whether the degree of localization in infected tissue is 
dependent on the intensity of infection. A well estab- 
lished model of pneumonia caused by Klebsiella pneu- 
moniae in rats was used for the present investigations. 
Materials and Methods 
Hydrogenated soybean phosphatidylinositol (HPI), 
hydrogenated soybean phosphatidylcholine (HPC), egg 
phosphatidylglycerol (PG) and egg phosphatidylcholine 
(PC) were obtained from Avanti Polar Lipids (Alabas- 
ter, AL). Cholesterol was from Sigma (St. Louis, MO). 
67Ga-citrate and L~lin_chloride were from Frosst 
(Quebec, Canada). Deferoxamine mesylate (DF) was 
from Ciba-Geigy (Basel, Switzerland). The acetate form 
of AG1X2 resin (acetate form, 200-400 mesh) was 
from Bio-Rad (Richmond, CA). 
Liposomes. Liposome preparations consisted of ei- 
ther HP I :HPC:Cho l  in a molar ratio 1:10:5 or 
PG : PC : Chol in a molar ratio 1 : 10 : 5. Liposomes were 
prepared as described previously [13] with some modi- 
fications. In brief, a chloroform/methanol (9:1, v/v)  
solution of the lipid mixture was evaporated to dryness 
in a round-bottomed flask. The lipids were redissolved 
in 2 ml of cyclohexane and were lyophilized. Multi- 
lamellar vesicles were formed by Vortex mixing of the 
lipid film in a buffer solution containing 10 mM Hepes, 
150 mM NaC1 and 25 mM DF (pH 7.4). Lipid concen- 
tration was 100 /zmol/ml. Vortex mixing was per- 
formed for 12 20-s periods at room temperature or, in 
the case of HPI : HPC : Chol liposomes at 62°C because 
of the high transition temperature of the phospholipids 
used. After Vortex mixing HP I :HPC:Cho l  liposomes 
were incubated for 1 h at 62°C. Liposomes were ex- 
truded 10 times through polycarbonate filters of 0.05 
/~m pore size (Nuclepore; Pleasanton, CA), using an 
extruder device from Lipex Biomembranes (Vancouver, 
Canada). For sizing of the HPI : HPC : Chol liposomes 
the extruder device was preheated to 62°C. Liposomes 
were separated from non-entrapped DF by gel filtra- 
tion on a Sephadex G-50 columm (Pharmacia, Upp- 
sala, Sweden) with 10 mM Hepes and 150 mM NaCI 
(pH 7.4) as the elution buffer. Phospholipid concentra- 
tion was determined by a phosphate assay [14]. Mean 
particle size was determined by dynamic light scatter- 
ing (Malvern 4700 system, Malvern, U.K.). As a mea- 
sure of the particle size distribution of the dispersion 
the system reports a polydispersity index. This index 
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ranges from 0.0 for an entirely monodisperse up to 1.0 
for a completely polydisperse system. The mean parti- 
cle size of the liposomes used was 100 + 4 nm with a 
polydispersity index of 0.13 + 0.02 (mean + S.D. of 9 
preparations) for the HPI : HPC : Chol liposomes, and 
110 + 9 nm with a polydispersity index of 0.21 + 0.07 
(mean + S.D. of 3 preparations) for the PG : PC : Chol 
liposomes. Liposomes were stored at 4°C under nitro- 
gen for at most 24 h. 
Radiolabeling of liposomes. The liposomes were radi- 
olabeled with 67Ga-deferoxamine (67Ga-DF) as de- 
scribed by Gabizon et al. [15]. The labeling resulted in 
formation of 67Ga-DF complex in the aqueous interior 
of liposomes. Non-entrapped 67Ga-oxine was removed 
by passing the liposome suspension through an anion- 
exchange resin (AG1X2). 
Animals and Infection. Female R strain albino-rats 
(specific pathogen flee; 14 to 18 weeks old; weight, 185 
to 215 g; bred at ITRI-TNO, Rijswijk, The Nether- 
lands) were used in all experiments. Experimental in- 
fection was induced using a Klebsiella pneumoniae 
strain (ATCC 43816, capsular serotype 2). Cultures 
were obtained by incubation for 16 h at 37°C in Iso- 
Sensitest broth (Oxoid, London, U.K.). After proper 
dilution and reincubation for 2 h at 37°C suspensions 
of logarithmically growing bacteria were prepared. A 
unilateral pneumonia (left lung) was produced as de- 
scribed previously [16]. In brief, rats were anesthetized 
with fluanisone (HypnormR; Duphar B.V., Amsterdam, 
The Netherlands) and pentobarbital (Abbott Laborato- 
ries, North Chicago, IL). The left main stem bronchus 
was intubated and the left lung was inoculated with 
0.02 ml of saline suspension containing 105 cfu of K. 
pneumoniae. After bacterial inoculation the narcotic 
antagonist Nalorphine bromide (Onderlinge Pharma- 
ceutische Groothandel, Utrecht, The Netherlands) was 
injected. The severity of the resulting infection in the 
lung was assessed by measuring the increase in bacte- 
rial numbers as well as increase in weight of the 
infected lung tissue. Numbers of bacteria in the left 
lung and right lung were quantitated as follows. Ani- 
mals were killed, the left lung and the right lung were 
removed separately, weighed and homogenized in 20 
ml of phosphate-buffered saline (PBS) for 30-s at 10 000 
rpm in a VirTis homogenizer (VirTis, Gardiner, NY). 
Serial 10-fold dilutions of homogenates were prepared. 
Vols. of 0.2 mt of each dilution as well as 1 ml vols. of 
the undiluted lung homogenate were spread on tryp- 
tone soy agar (Mast International, Merseyside, U.K.). 
The histological features of the pneumonic lesions 
were studied after fixation of the lungs by injecting the 
trachea with 10% formalin under constant pressure to 
reexpand the lungs. Segments of the left lung were 
then dehydrated in ethanol and toluol, embedded in 
paraffin, sectioned and stained with hematoxylin-eosin 
or by the Gram stain technique. 
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Biodistribution studies. In uninfected and infected 
rats, liposome blood circulation time and localization 
of l iposomes in liver, spleen, kidney, left lung and right 
lung was determined using the high affinity ~'7Ga-DF 
complex as a liposome marker. Correction for the 
blood content of the tissues was performed using 
~In-ox ine- labe led  syngeneic erythrocytes injected in- 
travenously 10 rain before dissection. Labeling of ery- 
throcytes was performed as described by Heaton et al. 
[17]. Liposomes were injected intravenously in a vol. of 
0.9 ml at doses of 5, 10, 15, 20 or 25 /xmol liposomal 
lipid per rat (200 g). At different time intervals after 
injection of l iposomes blood samples of 1 ml were 
obtained by retroorbital bleeding under CO x anesthe- 
sia. Then the rats were killed, and the spleen, kidney, 
left lung (one lobe), right lung (four lobes) and liver 
were removed. Radioactivity was quantitated in a y- 
counter (Minaxy 5530, Packard Instruments,  Downers 
Grove, U.S.A.). Encapsulated ('TGa served as a marker 
to determine the distribution of intact l iposomes in the 
various tissues. 
Statistical analysis. Differences in blood circulation 
time and localization in liver and spleen between 
HPI : HPC : Chol l iposomes and PG : PC : Chol lipo- 
somes were statistically evaluated by using the Wilcoxon 
signed rank test (two tailed). Student's t test was used 
for evaluation of differences in blood level and hep- 
atosplenic uptake of HPI : HPC:  Chol l iposomes be- 
tween infected rats and uninfected rats. The Spearman 
rank test was used to calculate whether the localization 
of HPI : HPC" Chol l iposomes or PG : PC : Chol lipo- 
somes in infected left lung was correlated with the 
increase in weight of the left lung. In addition, this test 
was used to detect whether there was a relationship 
between left hmg localization and in.iccted liposomal 
lipid dose. 
Results 
Biodistribution o f  HP1 : HPC : Chol liposomes and 
PG : PC:  Chol liposomes in uninfected rats 
Both types of l iposomes under  investigation 
(HPI : HPC : Chol and PG : PC : Chol liposomes) had a 
similar mean diameter of about 100 nm. The liposome 
blood circulation time and localization of liposomes in 
liver, spleen, kidney and lung after i.v. administration 
(15 ~mol  liposomal lipid per rat) are shown for both 
types of l iposomes in Table I. The HP I :HPC:Cho l  
l iposomes were el iminated from the bloodstream at a 
much lower rate than the PG:PC:Cho l  liposomes 
(P  = 0.0001). At 10 h after administration, 23.4 _+ 0.6%~ 
(mean _+ S.E.) of the administered dose of HPI : HPC : 
Chol l iposomes was still present in the circulation 
compared to 2.9_+ 0.3% in the case of PG:PC:Cho l  
liposomes. The relatively long blood circulation time of 
the HPI : HPC : Chol liposomes was accompanied by 
initially low uptake of l iposomes by liver and spleen (at 
0.5 h after administration being 4.8 and 0.2%, respec- 
tively), which gradually increased with time (up to a 
maximum of 25.8 and 1.2%, respectively, at 16 h after 
l iposome administration). At 0.5 h after administration 
total recovery of l iposomes based on blood, liver, 
spleen, kidney and lung uptake was 93%. The initial 
uptake of PG:PC:Cho l  l iposomes by liver and spleen 
at 0.5 h after administration was significantly increased 
TABLE I 
Biodistribution of °7Ga-DF labeled liposomes in uninfected rats at t'arious time intercals after injection 
Liposomes composed ofHPI :HPC:Chol (molar atio, 1: 10:5) or PG:PC:Chol (molar atio, 1:1(1:51 were injected intravenously at a dose of 15 
/zmol iposomal lipid per rat. Data are expressed as mean + S.E. of four rats. 
Liposome Tissue radioactivity (% of injected ose) 
composition 0.5 h 5 h 10 h 16 h 24 h 
HPI : HPC : Chol 
blood 81.1 _+ 4.3 61.6 ± 2.5 23.4 ± 0.6 1 (}.2 +_ 11.5 4.(1 ± (}.7 
liver 4.8 ± 0.8 10.4 ± 1.7 22.2 ± 1.5 25.8 + 0.6 22.8 + 1.4 
spleen 0.2 ± 0.1 0.6 ± 0.2 1.4 + 0.3 1.2 + 0.2 0.8 + 0.1 
kidney 6.2 ± 0.7 0.8 + O. 1 1.0 ± O. 1 1.3 + O. 1 (1.9 ± t1.2 
lung 0.5 +_ 0.3 0.04 ± 0.0 0.2 + 0.0 0.1 ± 0.0 0.1 + 0.0 
recovery 92.8 ± 3.3 73.7 + 1.4 48.2 + 1.5 38.5 + 0.6 28.5 + 1.5 
PG : PC : Chol 
blood 41.9 ± 1.3 11.7 ± 1.2 2.9 + 0.3 1.8 ± 0.1 0.7 ± (/.2 
liver 28.4 _+ 1.3 16.2 + 0.7 10.1 + 0.6 9.6 ± 0.3 9.0 ± 0.2 
spleen 2.3 ± 0.5 4.3 + 0.3 2.3 + 0.2 2.3 ± 0.1 2.4 + 0.4 
kidney 2.9 + 0.6 1.8 ± ().2 1.1 ± 0.1 0.6 + 0.1 0.9 ± 0. I 
lung 1.2+0.1 0.8±0.1 0.3 ±0.1 0.1 ±0.0 0.1 ±0.0 
recovery 76.6 ± 1.9 34.9 ± 1.3 16.7 + 0.4 14.4 ± 0.1 13.1 ± 0.7 
(P = 0.03) compared to HPI : HPC : Chol liposomes be- 
ing 28.4% and 2.3%, respectively. Concomitantly the 
blood circulation time of PG:PC:Cho l  liposomes was 
relatively short and significantly reduced (P = 0.0001) 
compared to that of the HPI : HPC : Chol liposomes. 
Total recovery of PG:PC:Cho l  liposomes based on 
blood, liver, spleen, kidney and lung uptake at 0.5 h 
after administration was 77%. 
Course of K. pneumoniae lung infection 
After inoculation of the left lung with 105 cfu of K. 
pneumoniae a progressive development of the infection 
started. Within 3-4 days bacterial numbers in the left 
lung increased up to 2 .10  u). The involvement of the 
left lung tissue in the infectious process was clearly 
demonstrated (Fig. 1). Substantial bacterial increase 
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was associated with an increase in severity of infection 
reflected by an increase in weight of the infected left 
lung from 0.5 up to 2 g. (Macroscopic examination 
revealed that large parts of the left lung were involved 
in the infectious process.) Histological examination re- 
vealed that the pneumonic lesions were characterized 
by edema fluid, large numbers of Gram-negative bacilli 
and a cellular infiltrate composed of polymorphonu- 
clear leukocytes and a few macrophages. Within 3-4 
days all rats had bacteria in the blood, resulting in the 
appearance of bacteria in other tissues such as the 
right lung in which bacterial numbers ranged from 10 
up to 109 (Fig. 1). This, however, was not associated 
with development of an infectious process as reflected 
by the absence of increase in weight of the right lung 
and confirmed by histological examination. 
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Fig. 1. Course of Klebsiella pneumoniae lung infection after inoculation of the left lung with 105 cfu of Klebsiella pneumoniae. Increase in 
bacterial numbers and increase in weight of infected lung tissue was determined in a group of 44 infected rats (o). Weight of uninfected lung 
tissue was determined in a group of 10 uninfected rats ( + ). 
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Fig. 2. Biodistribution of 67Ga-DF labeled HPI :HPC:Chol  (molar ratio, 1 : 10:5) liposomes in rats at various intervals after injection. A dose of 
15 ~zmol iposomal ipid per rat was injected intravenously in rats with Klebsiella pneumoniae lung infection (e) or in uninfected rats (<~). 
Bloodlevel ( ), hepatosplenic uptake ( - -  - -  - -) .  Data are expressed as mean values for groups of four rats. 
Biodistribution of HPI : HPC : Chol liposomes in infected 
uersus uninfected rats 
The influence of K. pneumoniae lung infection on 
the blood circulation time and hepatosplenic uptake of 
HPI : HPC : Chol liposomes was determined by compar- 
ing the biodistribution in uninfected rats and infected 
rats at 3 days after bacterial inoculation of the left lung 
(Fig. 2). The patterns of hepatosplenic uptake and 
blood circulation of liposomes were similar in unin- 
fected and infected rats. Only at 0.5 h after administra- 
tion hepatosplenic uptake of liposomes was signifi- 
cantly higher in infected rats compared to uninfected 
rats (P = 0.001), and only at 5 h after administration 
the amount of liposomes circulating in the blood was 
significantly reduced in infected rats compared to unin- 
fected rats (P= 0.007). Total recovery of iiposomes 
from blood, liver, spleen, kidney and lung at 0.5 h after 
administration in infected rats was 92%, being not 
significantly different from total recovery in uninfected 
rats. 
Localization of  HPI  : HPC : Chol liposomes and 
PG : PC : Chol liposomes in lung tissue 
It was investigated whether the prolonged liposome 
blood circulation time of HPI : HPC : Chol liposomes 
was parallelled by enhanced localization of liposomes 
in infected left lung tissue. At 16 h after administration 
of 15 tzmol HP I :HPC:  Chol liposomes per rat about 
10% of the injected liposome dose was still circulating 
in the blood (Fig. 2). At that time localization of 
liposomes in lung tissue was determined in a group of 
44 rats with varying intensity of infection. Bacterial 
numbers in the infected left lung ranged from 105 up 
to 2.101°, and weight of the infected left lung ranged 
from 0.45 up to 2.2 g. In Fig. 3 it is shown that in rats 
with substantially increased bacterial numbers in the 
left lung the degree of localization of liposomes was up 
to 10-fold higher compared to the degree of localiza- 
tion of liposomes in the left lung of uninfected rats. 
Increased localization of liposomes appeared to be 
strongly correlated (r = 0.93, P < 0.001) with the sever- 
ity of infection manifested by the increase in weight of 
the infected left lung, as shown in Fig. 4. In the right 
lung of infected rats bacterial numbers ranged from 10 
up to 10 9 . No development of an infectious process and 
parallel increase in lung weight was observed. Localiza- 
tion of liposomes in the right lung of infected rats was 
not increased compared to the localization in the right 
lung of uninfected rats (Fig. 3). 
The localization of the relatively short circulating 
PG:PC:Cho l  liposomes in infected left lung tissue at 
16 h after administration was determined in a group of 
20 rats with varying intensity of infection and com- 
pared to the localization of long circulating 
HP I :HPC:Cho l  liposomes in infected left lung tissue 
of 20 rats with similar degrees of intensity of infection 
(left lung weights were in the range of 0.7 up to 2.0 g 
(Fig. 5). Lung localization of PG:PC:Cho l  liposomes 
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Fig. 3. Localization of 67Ga-DF labeled HP I :HPC:Cho l  (molar ratio, 1:10:5) liposomes in the left lung and right lung of rats at 16 h after 
injection in relation to the bacterial numbers in the lung. A dose of 15 tzmol liposomal ipid per rat was injected intravenously in a group of 44 
rats with Klebsiella pneumoniae lung infection (e) or in a group of 10 uninfected rats ( + ). 
was significantly lower (P = 0.0008) compared to the 
localization of HPI : HPC : Chol liposomes. 
Effect of liposomal ipid dose on the degree of localiza- 
tion of HPI: HPC : Chol liposomes in lung tissue of in- 
fected rats 
HPI : HPC : Chol liposomes were administered to in- 
fected rats with increased left lung weights ranging 
from 0.7 up to 2.0 g at various doses ranging from 5 
/~mol up to 25 izmol liposomal ipid per rat. Localiza- 
tion of liposomes in infected left lung tissue increased 
with increasing liposomal dose from 5 /~mo! up to 15 
Izmol (r = 0.83, P = 0.006), whereas after administra- 
tion of higher liposomal doses no further increase in 
localization was observed (Fig. 6). Also in the right 
lung a dose-related increase in localization of lipo- 
somes was observed. However, this increase was signifi- 
cantly less (r = 0.74, P = 0.014) compared to that ob- 
served in the infected left lung. 
Discussion 
The development of long circulating lip•some for- 
mulations has expanded considerably the potential 
therapeutic value of i.v. administered liposomes [8- 
12,18]. These new types of liposomes have already been 
used in animals to deliver cytotoxic drugs more selec- 
tively to tumors and improve targeting of ligand-bearing 
liposomes to target cells within the vascular system 
[9,19]. In addition, it has been shown that encapsula- 
tion of the anticancer drug doxorubicin in long circulat- 
ing liposomes results in remarkable alterations in phar- 
mac•kinetics and tissue distribution of the drug [9]. In 
the present study, such liposomes have been applied to 
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Fig. 4. Effect of the severity of infection on the localization of +'TGa-DF labeled HPI :HPC:Chol (molar ratio, 1 : 10:5) liposomes in the left lung 
of rats at 16 h after injection. The increase in weight of the infected left lung was taken as measure of the intensity of the infection. A dose of 15 
/zmol liposomal ipid per rat was injected intravenously in a group of 44 rats with Klebsiella pneumoniae infection (el or in a group of 10 
uninfected rats ( + ). 
enhance the localization of liposomes in infected lung 
tissue. 
In the past few years a number of studies were 
published in which several important characteristics of 
liposomes determining the biodistribution of liposomes 
after intravenous administration were identified [8- 
12,18]. Factors contributing to prolongation of lip•- 
some circulation times and the stability of tiposomes in 
blood are reduction of lip•some size, and modifications 
of the bilayer composition yielding a negative charge, 
increased rigidity of the bilayer and increased hydro- 
philicity of the liposomal surface. The most favorable 
results were obtained with small sized liposomes con- 
taining cholesterol and solid-phase phospholipids such 
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Fig. 5. Effect of the severity of infection on the localization of 67Ga-bF labeled liposomes in the left lung of rats at 16 h after injection. The 
increase in weight of the infected left lung was taken as measure of the intensity of the infection. HPI:HPC:Chol (molar ratio, 1: 10:5) 
liposomes (el and PG:PC:Chol (molar ratio, 1:10:5) liposomes (A) were injected intravenously into rats with Klebsiella pneumoniae lung 
infection at a dose of 15/zmol ipid per rat. 
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Fig. 6. Effect of liposomal lipid dose on degree of localization of ~7Oa-DF labeled HPI:HPC:Chol (molar atio, 1:10:5) liposomes in the left 
lung (e) and right lung (o) of rats at 16 h after injection. Liposomes were injected intravenously into rats with Klebsiella pneumoniae lung 
infection at various doses ranging from 5 up to 25 ~mol iposomal lipid per rat. Data are expressed asmean _+ S.E. values for groups of four rats. 
as DSPC, in which the negatively charged monosialo- 
ganglioside GM-1 or HPI are included in the bilayer. 
In this study the potential of long circulating liposomes 
for enhanced drug delivery to sites of infection was 
addressed using an experimental pneumonia rat model. 
It was investigated whether intravenous administration 
of one of these liposome formulations with prolonged 
blood circulation time may result in significant localiza- 
tion of liposomes in infected lung tissue and whether 
the degree of localization is dependent on the intensity 
of infection. Inoculation of the left lung with a highly 
virulent K. pneumoniae strain resulted in acute infec- 
tion in which the involvement of the lung tissue in the 
infectious process was reflected by a parallel increase 
in weight of the left lung. Biodistribution of liposomes 
was followed using a high-affinity 67Ga-DF complex as 
aqueous liposomal marker. Gabizon et al. showed that 
this complex is very appropriate for in vivo tracing of 
liposomes due to the advantages of minimal transloca- 
tion of radioactive label to plasma proteins and the 
rapid renal clearance rate when the label is released 
from the liposomes extracellularly [15]. 
The two types of liposome used were relatively small 
and similar in size (mean particle diameter about 100 
nm), but differed in lipid composition, being 
HPI  : HPC : Chol and PG : PC : Chol, respectively. For 
HP I :HPC:Cho l  liposomes with the same molar ratio 
of lipids a prolonged blood circulation time has been 
demonstrated in mice by Gabizon et al. [8,10]. They 
reported that 9% of the injected liposome dose was 
recovered from the blood at 24 h after administration. 
We were able to confirm their findings in our experi- 
mental study in rats. The HP I :HPC:Cho l  liposomes 
showed relatively long blood circulation time: at 10, 16 
and 24 h after administration, 23, 10 and 4% of the 
injected dose, respectively, was still circulating in the 
bloodstream. However, changing the lipid composition 
into PG:PC:Cho l  while maintaining a similar size 
resulted in a significant decrease in blood circulation 
time. The observations with the two types of liposome 
suggest hat prolonged liposome circulation correlates 
with reduced hepatosplenic uptake. 
Comparison of the behavior of long circulating lipo- 
somes in uninfected and infected rats revealed that the 
bacterial ung infection did not affect the biodistribu- 
tion markedly. The slightly increased hepatosplenic 
uptake of liposomes observed at 0.5 h after injection 
may be explained by an increased uptake of liposomes 
by liver and spleen macrophages being activated by 
bacteria circulating in the blood at this stage of lung 
infection. Importantly, however, biodistribution with 
respect to lung uptake was clearly modified. It was 
observed that the long circulating HP I :HPC:Cho l  li- 
posomes howed significant localization in infected left 
lung tissue. At 16 h after administration when about 
10% of injected liposomes was still present in the 
bloodstream, localization of liposomes in the infected 
left lung was increased up to 10-fold compared to the 
left lung of uninfected rats. The increased degree of 
localization of liposomes in the infected left lung is 
likely to be related to the local infectious process, 
because in the right lung of the same animal in which 
bacteria were present without signs of development of 
an infectious process, the degree of localization of 
liposomes was not increased compared to the degree of 
localization observed in uninfected rats. Interestingly, 
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the increased localization of liposomes in the infected 
left lung appeared to be highly correlated with thc 
intensity of the infection, the latter being reflected by 
the parallel rise in weight of the infected left lung. 
Compared to HPI : HPC : Chol liposomes localization 
of PG : PC : Chol liposomes in the infected left lung was 
significantly lower. This suggests that the degree of 
localization of liposomes in the infected tissue is de- 
pendent on the residence time of liposomes in the 
blood compartment. Prolonged circulation would en- 
able the liposomes to extravasate more efficiently. Ex- 
travasation of liposomes at the site of infection is 
probably related to locally increased capillary perme- 
ability or damaged endothelium secondary to the infec- 
tious process. Besides the long residence time of lipo- 
somes in the blood compartment, phagocytosis of lipo- 
somes by inflammatory cells infiltrating into the in- 
fected tissue may also acount for enhanced localization 
of liposomes in the infected lung. The role of inflam- 
matory cells in this respect has to be elucidated. 
It appeared that the extent of localization of lipo- 
somes in infected tissue is dependent on the liposomal 
close administered, saturating around a dose of 15 
p.mol l ipid/rat. This observation suggests that en- 
hanced localization of liposomes in infected tissue is 
not only the result of extravasation of liposomes at the 
site of infection through leaky or damaged endothe- 
lium, since in that case a saturation effect is not 
expected. The result indicates perhaps cellular and/or  
protein involvement. 
In summary the experiments presented here indi- 
cate that liposomes with prolonged blood circulation 
time achieve increased localization in infected lung 
tissue compared to conventional (short circulating) li- 
posomes. Lung localization of liposomes is dependent 
on the intensity of infection, is significantly increased 
from the moment that bacterial multiplication in the 
lung results in a local inflammatory response, and 
appeared to be correlated with increased involvement 
of the lung tissue in the infectious process reflected by 
a rise in weight of the infected tissue. Whether [ipo- 
somes with prolonged blood circulation time can bc 
used for improved delivery of antibiotics to thc site of 
infection is the subject of current investigations. 
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